摘要
对26省(区、市)增补的纳入基本药物管理的非基本药物目录进行分析,并与国家基本药物目录的构成进行比较。26省(区、市)共增补非基本药物数据5 666条,其中化学药品和生物制品占58%,中药占42%,26省(区、市)增补的化学药品、生物制品和中药的构成与国家基本药物目录基本相同。
The additional non-essential drug list is collected and analyzed, and the constitution of state essential drug list is compared. The total data of supplement non-essential drug are 5 666, in which the western medicine aeeounting for 58% , the traditional Chinese Medieine accounting for 42%. The structure of additional non-essential drug list is almost the same as Ihe state essential drug list.
出处
《中国卫生经济》
北大核心
2012年第1期34-36,共3页
Chinese Health Economics